Evidence map›Paper›PMID 38597974›Full record

ArticlePediatric nephrology (Berlin, Germany)2024

Medication fill duration in pediatric hypertension: adherence, blood pressure control, and disparities.

Meghan M McLaughlin, Conrad D Gleber, Hongyue Wang, Jill S Halterman, Marc B Lande

Abstract read
PubMed Publisher
In one paragraph

Article in Pediatric nephrology (Berlin, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Meghan M McLaughlinDepartment of Pediatrics, University of Rochester Medical Center, Pediatric Nephrology, 601 Elmwood Ave, Box 777, Rochester, NY, 14642, USA. Meghan_McLaughlin@URMC.Rochester.edu.ORCID 0009-0006-1465-922X
Conrad D GleberDepartment of Medicine, University of Rochester Medical Center, Rochester, NY, USA.
Hongyue WangDepartment of Biostatistics, University of Rochester Medical Center, Rochester, NY, USA.
Jill S HaltermanDepartment of Pediatrics, University of Rochester Medical Center, Rochester, NY, USA.
Marc B LandeDepartment of Pediatrics, University of Rochester Medical Center, Pediatric Nephrology, 601 Elmwood Ave, Box 777, Rochester, NY, 14642, USA.
University of Rochester Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMedication nonadherence is a barrier to hypertension control. The Centers for Disease Control and Prevention recommends prescribing 90-day fills for maintenance medications yet antihypertensives are often dispensed as 30-day fills. Our objectives were to examine how often patients receive 30-day supplies of medication despite prescriptions for longer duration and to examine the effect of medication fill duration on adherence and hypertension control.

methodsWe conducted a retrospective cohort study of pediatric patients with hypertension over a 3-year period. For each patient, days prescribed per fill were compared to days dispensed per fill using pharmacy reports and insurance claim data. Proportion of Days Covered (PDC) was calculated to estimate adherence. Hypertension control was determined by provider assessment of control and blood pressure measurement at the final visit.

resultsFinal cohort included 449 patients. A total of 70% had at least one prescription for ≥ 90 days but only 37% had at least one dispense for ≥ 90 days. There was no difference in the likelihood of being prescribed a 90-day fill by insurance type (public vs. private); however, patients with public insurance were less likely to be dispensed a 90-day fill (OR = 0.068, p < 0.001). Patients who received 90-day fills had better adherence (median PDC 77.5% vs. 58.1%, p < 0.001) and were more likely to have hypertension control based on provider assessment.

conclusionsLonger fill duration is associated with improved adherence and hypertension control. Patients with public insurance are markedly less likely to be dispensed 90-day fills, a modifiable barrier to improving adherence.

Indexed as

Antihypertensive AgentsBlood PressureDrug MonitoringHypertensionAdolescentChildChild, PreschoolFemaleHealthcare DisparitiesHumansMaleRetrospective StudiesTime FactorsAntihypertensive AgentsAdherenceHealth disparitiesHypertensionRefill data

Identifiers

PMID38597974
OpenAlexW4394677984

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.